Media - Abzena


Manufacturing Capabilities Brochure

From Cell Line Development to Commercial Manufacturing



World ADC Europe

26 March 2018

This is the 8th staging of Europe’s leading antibody-drug conjugation conference. The meeting is Europe’s leading[...] Read more

The Future of Swedish & Danish Life Science

22 March 2018

Join the Abzena team to celebrate the success of the Nordic life science industry and explore the opportunity to benefit[...] Read more


Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates

Antibody-drug conjugates (ADCs) are a promising class of anticancer agents which have undergone substantial development[...] Read more


Half year results: Growth strategy progressing

Cambridge, UK, 12 December 2017 – Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life[...] Read more

Abzena secures ADC manufacturing services contract

Cambridge, UK, 11 December 2017 – Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life[...] Read more


We’re changing the way we brand our businesses

To provide our Partners with a single identity for the services and technologies offered across Antitope, PacificGMP,[...] Read more

Interested in our services? Get In Touch